Research on the Changes and Predictions of the Burden of Type 2 Diabetes Mellitus in Pacific Island Countries from 1990 to 2019

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2023 Dec 21

PMID 38127863

Authors

Yan Li

Hao Zhang

Yi Jiang

Affiliations

Soon will be listed here.

Abstract

Aims: To assess the burden of type 2 diabetes in Pacific Island countries and predict future trends.

Methods: We analyzed and processed data using R and Excel software, performed Joinpoint 4.7.0 software analysis to investigate changing trends in disease burden, and used an autoregressive integrated moving average model to forecast future trends.

Results: Our study showed that from 1990 to 2019, the burden of type 2 diabetes in Pacific Island countries continues to increase, with the standardized incidence rate showing the most significant growth. Moreover, there were significant differences in the burden of type 2 diabetes between regions. In 2019, American Samoa had the highest standardized incidence rate, while Fiji had the highest standardized death rate and disability-adjusted life year rate. The standardized incidence rate peaked at ages 65-69 years, while the standardized death rate and disability-adjusted life year rate peaked at ages 95 years and 70-74 years respectively. Type 2 diabetes burden was higher among males than females. Based on our forecasting, from 2020 to 2030, the standardized incidence rate is expected to continue to rise, while the standardized death rate and disability-adjusted life year rate will slowly decline.

Conclusions: Our study highlights that the burden of type 2 diabetes in Pacific Island countries has been increasing from 1990 to 2019. Therefore, it is imperative to strengthen disease prevention and control measures in the region.

Citing Articles

Burden of type 2 diabetes due to high body mass index in different SDI regions and projections of future trends: insights from the Global Burden of Disease 2021 study.

Ding Y, Deng A, Qi T, Yu H, Wu L, Zhang H Diabetol Metab Syndr. 2025; 17(1):23.

PMID: 39833964 PMC: 11748324. DOI: 10.1186/s13098-024-01554-y.

References

. Five insights from the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1135-1159. PMC: 7116361. DOI: 10.1016/S0140-6736(20)31404-5. View

. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

Abdul-Ghani M, DeFronzo R . Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol. 2010; 2010:476279. PMC: 2860140. DOI: 10.1155/2010/476279. View

Thu Win Tin S, Kenilorea G, Gadabu E, Tasserei J, Colagiuri R . The prevalence of diabetes complications and associated risk factors in Pacific Islands countries. Diabetes Res Clin Pract. 2013; 103(1):114-8. DOI: 10.1016/j.diabres.2013.09.017. View

Mau M, Kaholokula J, West M, Leake A, Efird J, Rose C . Translating diabetes prevention into native Hawaiian and Pacific Islander communities: the PILI 'Ohana Pilot project. Prog Community Health Partnersh. 2010; 4(1):7-16. PMC: 2852179. DOI: 10.1353/cpr.0.0111. View

McLennan A, Ulijaszek S . Obesity emergence in the Pacific islands: why understanding colonial history and social change is important. Public Health Nutr. 2014; 18(8):1499-505. PMC: 10271720. DOI: 10.1017/S136898001400175X. View

. 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2021; 45(Suppl 1):S8-S16. DOI: 10.2337/dc22-S001. View

Armstrong R . When to use the Bonferroni correction. Ophthalmic Physiol Opt. 2014; 34(5):502-8. DOI: 10.1111/opo.12131. View

Hsu W, Boyko E, Fujimoto W, Kanaya A, Karmally W, Karter A . Pathophysiologic differences among Asians, native Hawaiians, and other Pacific Islanders and treatment implications. Diabetes Care. 2012; 35(5):1189-98. PMC: 3329855. DOI: 10.2337/dc12-0212. View

10.

Lin S, Tukana I, Linhart C, Morrell S, Taylor R, Vatucawaqa P . Diabetes and obesity trends in Fiji over 30 years. J Diabetes. 2015; 8(4):533-43. DOI: 10.1111/1753-0407.12326. View

11.

Chawla S, Kaur S, Bharti A, Garg R, Kaur M, Soin D . Impact of health education on knowledge, attitude, practices and glycemic control in type 2 diabetes mellitus. J Family Med Prim Care. 2019; 8(1):261-268. PMC: 6396605. DOI: 10.4103/jfmpc.jfmpc_228_18. View

12.

Spanakis E, Golden S . Race/ethnic difference in diabetes and diabetic complications. Curr Diab Rep. 2013; 13(6):814-23. PMC: 3830901. DOI: 10.1007/s11892-013-0421-9. View

13.

Aldwell K, Caillaud C, Galy O, Frayon S, Allman-Farinelli M . Tackling the Consumption of High Sugar Products among Children and Adolescents in the Pacific Islands: Implications for Future Research. Healthcare (Basel). 2018; 6(3). PMC: 6163880. DOI: 10.3390/healthcare6030081. View

14.

. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1204-1222. PMC: 7567026. DOI: 10.1016/S0140-6736(20)30925-9. View

15.

Karter A, Schillinger D, Adams A, Moffet H, Liu J, Adler N . Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE). Diabetes Care. 2012; 36(3):574-9. PMC: 3579366. DOI: 10.2337/dc12-0722. View

16.

Cannon A, Handelsman Y, Heile M, Shannon M . Burden of Illness in Type 2 Diabetes Mellitus. J Manag Care Spec Pharm. 2018; 24(9-a Suppl):S5-S13. PMC: 10408423. DOI: 10.18553/jmcp.2018.24.9-a.s5. View

17.

Popkin B, Hawkes C . Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses. Lancet Diabetes Endocrinol. 2015; 4(2):174-86. PMC: 4733620. DOI: 10.1016/S2213-8587(15)00419-2. View

18.

Baliunas D, Taylor B, Irving H, Roerecke M, Patra J, Mohapatra S . Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care. 2009; 32(11):2123-32. PMC: 2768203. DOI: 10.2337/dc09-0227. View

19.

Adams R . Improving health outcomes with better patient understanding and education. Risk Manag Healthc Policy. 2012; 3:61-72. PMC: 3270921. DOI: 10.2147/RMHP.S7500. View

20.

Geiss L, Wang J, Cheng Y, Thompson T, Barker L, Li Y . Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA. 2014; 312(12):1218-26. DOI: 10.1001/jama.2014.11494. View